| 1. |
中国抗癫痫协会.临床诊疗指南-癫痫病分册(2015修订版).北京:人民卫生出版社, 2015.
|
| 2. |
Santulli Lia, Coppola Antonietta, Balestrini Simona, et al. The challenges of treating epilepsy with 25 antiepilepticdrugs. Pharmacological Research, 2016, 107(5): 211-219.
|
| 3. |
Emilio Perucca, Torbjorn Tomson. The pharmacological treatment of epilepsy in adults. Lancet Neurol, 2011, 10(6): 446-456.
|
| 4. |
Torbjorn Tomson, Dina Battino, Emilio Perucca. Valproic acid after five decades of use in epilepsy: time toreconsider the indications of a time-honoured drug. Lancet Neurol, 2016, 15(5): 210-218.
|
| 5. |
Rheims S, Ryvlin P. Pharmacothrapy for tonic-clonic seizures. Expert Opin Pharmacother, 2014, 15(7): 1417-1426.
|
| 6. |
Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalizedand unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet, 2007, 369(9566): 1016-1026.
|
| 7. |
Scottish Intercollegiate Guidelines Network. SIGN143, Diagnosis and management of epilepsy in adults(2015).
|
| 8. |
National Clinical Guideline Centre (UK). NICE The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care(2012).
|
| 9. |
Tracy Glauser, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia, 2013, 54(3): 551-563.
|
| 10. |
Ben-Menachem E, Schmitz B, Tomson T, et al. Role of valproate across the ages: treatment of epilepsy in adults. Acte Neurol Scand, 2006, 184(Suppl): 14-27.
|
| 11. |
Yatham LN, Gaily E, K lviinen R, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord, 2013, 15(1): 1-44.
|
| 12. |
Grunze H, Canevini MP, Covanis A, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry, 2009, 10(2): 85-116.
|
| 13. |
Ghaderibarmi F, Tavakkoli N, Toqha M. Intravenous valproate versus subcutaneous sumatriptan in acute migraine attack. Acta Med Iran, 2015, 53(10): 633-636.
|
| 14. |
Torbjorn Tomson, Marson A, Boon P, et al. Valproate in the treatment of epilepsy in women and girls. Epilepsia, 2015, 56(7): 1006-1019.
|
| 15. |
Mengqian Wu, Nanya Hao, Bo Yan, et al. Status epilepticus in pregnant women with epilepsy after valproate adjustment: a case series. Seizure, 2016, 43(12): 39-41.
|
1/5
WeChat